Its receptor, EGFR, is often overexpressed and persistently activated in GBM, driving progression via pathways, including RAS/RAF/MEK/ERK, PI3K/AKT/mTOR, Src kinases, and STAT transcription factors. Here, SRC is linked to glioblastoma.